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The structures of enzymes catalyzing the reactions in central
metabolic pathways are generally well conserved as are their
catalytic mechanisms. The two types of 3-dehydroquinate
dehydratase (DHQase) are therefore most unusual since they
are unrelated at the sequence level and they utilize completely
different mechanisms to catalyze the same overall reaction.
The type I enzymes catalyze a cis-dehydration of 3-dehydro-
quinate via a covalent imine intermediate, while the type II
enzymes catalyze a trans-dehydration via an enolate interme-
diate. Here we report the three-dimensional structures of a
representative member of each type of biosynthetic DHQase.
Both enzymes function as part of the shikimate pathway,
which is essential in microorganisms and plants for the
biosynthesis of aromatic compounds including folate,
ubiquinone and the aromatic amino acids. An explanation for
the presence of two different enzymes catalyzing the same
reaction is presented. The absence of the shikimate pathway in
animals makes it an attractive target for antimicrobial agents.
The availability of these two structures opens the way for the
design of highly specific enzyme inhibitors with potential
importance as selective therapeutic agents.
The covalent intermediate in the type I DHQase reaction
(Fig. 1) can be trapped by borohydride reduction1. The trapped
enzyme–product complex of the type I DHQase of the human
pathogen Salmonella typhi has been crystallized2 and its structure
solved by multiple isomorphous replacement (MIR) to 
2.1 Å resolution (Table 1). The structure of the type II DHQase
from another human pathogen Mycobacterium tuberculosis has
also been solved using MIR to 2.0 Å resolution (Table 1). A stereo-
diagram of typical electron density from the two structure deter-
minations is shown in Fig. 2.
Both types of DHQase have completely different subunit archi-
tectures (Fig. 3). The overall topology of the type I DHQase is an
eight-stranded a/b-barrel, a very common fold that was first
reported for triose phosphate isomerase3. This parallel 
a/b-barrel arrangement has been found in other enzymes that
form an imine intermediate like the class I aldolases4, N-acetyl-
neuraminate lyase5 and dihydrodipicolinate synthase6. In contrast,
the type II DHQase subunit consists of a five-stranded parallel
b-sheet core flanked by four a-helices (Fig. 3c) arranged with a
similar overall topology to flavodoxin7.
The type I DHQase is a dimer with helices F, G and H at the
dimer interface (Figs 3a, 4a). Interestingly Arg 213, the key
residue for carboxylate recognition, previously identified by
chemical modification studies8, is located on the distorted helix G
at the subunit interface. The covalently linked product is at the
center of the barrel attached to Lys 170, which is located on
b-strand f (Fig. 3a) as it is in several of the other Schiff base-
dependent enzymes4–6 but not in transaldolase where the active
site lysine is on strand d rather than strand f (ref. 9). The g-G
region has several interactions that distort the pro-
tein chain. Met 203 and Met 205, whose side chains
both point into the active site near the substrate car-
boxylate, produce a main chain distortion at
Ser 204. Ala 206 at the start of helix G adopts an
epsilon conformation that allows the neighboring
Lys 207 to make a salt bridge with the C-terminal
carboxylate of Ala 252 from the other subunit. The
presence of Gly 209 and Gly 216 within the G helix
distorts it, and the substrate-coordinating, con-
served Arg 213 is located in the helix between these
two glycines. The dimeric nature of the cross-link-
ing of the G and H helices stabilizes both the dimer
and the C-terminal helix, and may help the h-H
loop to maintain its conformation. This loop con-
tains a conserved sequence that includes Gln 236
and Ser 232, which interact with the substrate car-
boxylate and the C-5 hydroxyl group, respectively.
The remaining helices F at the dimer interface inter-
act symmetrically with each other, with His 179
from one subunit interacting with Glu 190 and Gln
193 from the other. The main chain conformation
of the neighboring residue, His 194, is distorted,
although crystal contacts may also be a contributing
Fig. 1 The different stereochemistry and reaction mechanisms of the type I and II
DHQases. The water molecule associated with the formation and breakdown of the
imine (Schiff base) intermediate in the type I reaction scheme is not shown.



































factor. The interactions at the dimer interface and their juxtaposi-
tion to the active site may explain the observed increase in stability
of the protein following borohydride reduction of the product10.
Chemical modification and site-directed mutagenesis experi-
ments have suggested a role for a histidine residue (His 143) as a
general base abstracting the C-2 proton11,12. His 143 is positioned to
interact with Glu 86 through the protonated nitrogen Nd1. Glu 86
is strictly conserved in the monomeric type I DHQases, suggesting
an important functional role for the glutamate, perhaps in orient-
ing His 143 in a manner reminiscent of the serine proteases. Highly
conserved side chains from different regions of the protein orient
the substrate and place His 143 proximal to the C-2 side of the sub-
strate. The C-1 carboxylate binds to Arg 213 and Gln 236 while Glu
46, Arg 48 and Arg 82 share interactions with the C-4 and C-5
hydroxyl groups. Access to the active site from the N-terminal end
of the barrel is blocked by a b-hairpin, strands a1 and a2, and the
substrate is stacked parallel to Phe 225, which is also in the lower,
N-terminal side. The effect of this is to block any attack on the sub-
strate from below so that the cis elimination mechanism for water is
the only one possible.
In the type II DHQase the strand order of the b-sheet is 2, 1, 3, 4,
and 5 and the connections of the successive b/a units follow the
standard right-handed rule, which means that helices 2 and 3 are
on one side of the sheet and helices 1 and 4 are on the other. The
break in the polypeptide chain (Fig. 3c) is due to weak electron
density for residues 19–24. These residues form a flexible loop as
suggested by earlier limited proteolysis studies carried out on the
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enzyme in the absence of substrate13. The posi-
tion of the active site was suggested by the clus-
ter of conserved residues near the C-termini of
the b-strands 3, 4, and 5 (Fig. 3c). Two residues,
Arg 19 and Tyr 248, have been identified in earli-
er chemical modification and site-directed
mutagenesis studies as being essential for
enzyme activity. Both of these residues are on
the flexible loop but modeling studies indicate
that they can be readily fitted near the cluster of
conserved residues. It has been proposed that
the type II DHQases utilize a stepwise E1CB
(elimination unimolecular via conjugate base)
mechanism involving an enolate intermediate14
(Fig. 1). This mechanism requires base-cat-
alyzed abstraction of the axial proton at C2 lead-
ing to enolate formation followed by the
acid-catalyzed removal of the hydroxyl group at
the C1 position14 and the formation of product.
It is possible to assign roles for the conserved active site residues.
His 101 is likely to be involved in abstracting the axial hydrogen at
C2; its basicity would be elevated by the proximity of the carboxy-
late side chain of the conserved Glu 99, which forms a hydrogen
bond with the Ne2 atom of His 101. Site-directed mutagenesis has
already indicated that Arg 19 has a catalytic role and is therefore
likely to be involved in stabilization of the enolate intermediate8,14.
Arg 108 is in a suitable position to bind the substrate carboxylate.
The side chain involved in the acid-catalyzed removal of the
hydroxyl at C1 has not yet been identified. In addition, roles have
not yet been assigned for the other conserved active site residues
Tyr 24, His 81 and Asn 75. The latter might be involved in binding
the hydroxyl groups of the substrate.
In the dodecamer, the subunits of the type II DHQase are
arranged tetrahedrally as a tetramer of trimers with 23 symmetry
(Fig. 4b). Within each trimer there are strong electrostatic interac-
tions. A single monomer is in contact with each three-fold symme-
try-related subunit via five salt bridges. The two-fold interactions
(between the trimers) principally involve main-chain hydrogen
bonding between the two C-terminal b-strands, which, interesting-
ly, have the palindromic sequence Gly-Val-Ile-Val-Gly (residues
123–127). The isoleucine in this sequence is at the center of the two-
fold symmetry and the palindromic arrangement provides optimal
stacking of the hydrophobic side chains. In agreement with these
structural observations, dissociation of the dodecameric enzyme
with guanidine hydrochloride first produces a trimeric species15.
Fig. 2 Stereodiagrams of the electron density maps
for the types I and II 3-dehydroquinase. a, A view of
the active site region within the b-barrel, looking
into the site from the more open end of the barrel.
The electron density map (2Fo - Fc) calculated at 2.7 Å
resolution is noncrystallographically averaged and
solvent flattened and contoured at 1s. The bound
product is attached to Lys 170 at the C-3 position.
The substrate-interacting residues Gln 236, Ser 232,
Glu 46, Arg 48 and Arg 82 arise from the b-strands
and the loop regions of the C-terminal end of the
strands, whereas Arg 213 is located on the G helix.
The water molecule W1, which interacts with the C-4
hydroxyl group and the Schiff base nitrogen of
Lys 170, is also shown. b, A view of the region
around His 132 showing the typical quality of the
(2Fo - Fc) electron density map for the type II 3-dehy-
droquinase. There is no significant electron density
for residues in the loop between Arg 18 and Gly 25.
a
b
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The two DHQases described in this paper
are both components of the biosynthetic
shikimate pathway, and it is interesting to
consider why there might be two structurally
and mechanistically distinct forms of this
enzyme. The type I DHQases are found in
plants, fungi and many bacterial species
including archaebacteria, and are exclusively
biosynthetic. The type II enzymes are either
part of the shikimate pathway or form part of
the quinic acid utilization (qut) pathway,
which shares a common biochemical step
with the shikimate pathway16. The catabolic
qut pathway17,18, which occurs in saprophytic
fungi such as Neurospora crassa and
Aspergillus nidulans, provides a route for the
conversion of the abundant plant storage
compound quinic acid (or its esters) into
succinyl CoA for use as a major source of car-
bon and energy. The biosynthetic type II
enzymes occur in many bacterial species
including M. tuberculosis, Streptomyces coeli-
color and Helicobacter pylori. The qut path-
way, which depends on a storage compound
produced by higher plants, must have
evolved later than the shikimate pathway,
which was essential from the earlier stages of
evolution for the production of key aromatic
compounds including amino acids and
ubiquinone. We propose that the first type II
DHQases were new enzymes that were later-
ally recruited from an unknown ancestor to
permit a saprophytic adaptation to the
appearance of an abundant plant storage
compound. Initially these type II DHQases
were exclusively catabolic, but later they were
used in a biosynthetic role in some species.
This is consistent with the occurrence of
both a biosynthetic type I DHQase and a
catabolic type II DHQase in fungi such as N.
crassa19 and A. nidulans20. It also explains the
presence of a single dual- function type II
DHQase in Amycolatopsis methanolica21,
which appears to have lost the ancestral type
I enzyme. Evidence from sequencing of the
complete genomes of M. tuberculosis22 and H.
pylori23 indicates that these species have also
lost the type I DHQase and have only a type
Fig. 3 The structure of an enzyme subunit. a, A car-
toon of the type I DHQase from Salmonella typhi,
looking into the parallel a/b barrel. The product 
3-dehydroshikimate is shown in the center of the
molecule with the position of the imine-forming
Lys 170 to which it is covalently attached, and the
conserved side-chains involved in ligand binding,
also shown. b, A stereodiagram of the Ca trace of
the type I DHQase subunit. c, A cartoon of the type
II DHQase from Mycobacterium tuberculosis;
residues 19–24 were not included in the molecular
structure since there was insufficient electron den-
sity, indicating that this region is disordered. d, A
stereo diagram of the Ca trace of the type II









































II DHQase gene. It is also interesting to note that in N. crassa19
and A. nidulans20, transcriptional control of the quinate catabol-
ic pathway is provided by activator (QA-1F17, QUTA16) and
repressor (QA-1S17, QUTR16) proteins that are clearly related to
the multidomain AROM complex that is responsible for five of
the seven enzymatic activities making up the shikimate biosyn-
thetic pathway16,17,24.
The shikimate pathway is essential for the growth of microor-
ganisms and plants, but it is absent in animals25. The commercial
success of glyphosate as a broad-spectrum post emergence herbi-
cide has already established that the shikimate pathway enzymes
are excellent targets for herbicides26. The pathway enzymes have
also been proposed as targets for antimicrobial agents27 with
(6S)-6-fluoroshikimic acid already having been shown to be
active against aromatic biosynthesis28. Further, aroD strains that
lack the type I DHQase gene, from both S. typhi29 (in fact, an
aroC aroD double mutant) and Shigella flexneri30 have been
shown to make satisfactory live oral vaccines, the latter providing
monkeys with protection against oral challenge with live S.
flexneri 2457T. The availability of the structures of both types of
DHQases now opens the way for the structural design of
inhibitors of this earlier step in the pathway. The fact that there
are two mechanistically distinct forms of DHQase may allow the
development of selective inhibitors for the two types of enzyme.
This could be valuable in the selective therapy of slowly growing
organisms such as M. tuberculosis and H. pylori, which have only
the type II enzymes, in contrast with gut organisms such as
Escherichia coli, which have type I enzymes only.
Methods
Type I DHQase. Significant polymorphism between native and
heavy-atom crystals as well as among native crystals themselves hin-
dered the structure solution. However, monoclinic crystals of
enzyme inactivated by treatment with dehydroquinate and sodium
borohydride were grown in space group P21 with a = 60.49, b =
45.39, c = 85.47 Å, b = 95.48°, Z = 2 and a solvent content of 42%
(ref. 2). The data were processed using DENZO31, and the structure
solution and subsequent refinement of the structure were carried
out using programs from the CCP4 suite32 and X-PLOR33. Heavy-
atom sites were determined from difference Patterson maps and
refined with VECREF and then MLPHARE34. A final multiple isomor-
phous replacement (MIR) map was calculated to 2.7 Å resolution
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and the phasing analysis gave a figure of merit of 0.74. The map was
solvent flattened using the program DM35, and the polypeptide
chain was traced using both the map at 2.7 Å resolution and a low-
resolution (17–3.5 Å) map. Model building was carried out using the
program O36. Following a successful tracing of both independent
molecules, further maps were averaged in DM. Manual alignment
of the sequence in the electron density positioned the proposed
imine-forming residue Lys 170 in close proximity to electron density
associated with the bound substrate. Cycles of model building,
phase combination with the MIR phases, solvent flattening, symme-
try averaging and calculation of electron density maps were carried
out until all the residues and protein electron density were success-
fully fitted. No further phase combination was then carried out and
the independent molecules were fitted individually. Positional
refinement and simulated annealing were performed using all of
the data, initially in the range 12.0–3.5 Å and gradually extended to
2.1 Å, using two-fold noncrystallographic restraints throughout.
The imine-linked substrate and 137 water molecules were added.
Final refinement included individual isotropic B refinement but the
noncrystallographic restraints were not released. There were no
detectable differences between the two independent molecules
other than side chains involved in crystal contacts (main chain + Cb
r.m.s. = 0.041 Å). The average B-factor (all atoms) is 22.2 Å2.
Type II DHQase. DHQase from M. tuberculosis was purified and
crystallized as described37. Single-wavelength X-ray data were
recorded from crystals mounted in capillaries, as crystals were rela-
tively insensitive to radiation damage. The enzyme crystallized in
space group F23 with cell dimensions a = b = c = 127.9 Å. The asym-
metric unit contains a single enzyme subunit. Derivatives were
obtained by soaking potassium tetrachloroplatinate and mercury
cyanide, and MIRAS phases (multiple isomorphous replacement
with anomalous scattering) were calculated and refined using
MLPHARE34. Although the two mercury derivatives (1 and 2) had
identical mercury positions, they were treated as independent
derivatives since they differed in the mercury occupation. Electron
density maps calculated using both mercury derivatives were better
than maps computed from phases calculated from only one mercury
data set. The overall figure of merit for the MIRAS phasing was 0.4
for acentric reflection and 0.6 for centric reflections for data from
10 to 2.2 Å. Density modification with DM35 gave an interpretable
map. After a Ca trace was fitted into the MIRAS map using bones
generated by the program O36, a polyalanine trace was built consist-
ing of three polypeptide segments of 118 residues in total. The first
model had ~80% of the alanine residues replaced with the correct
side chains and was then subjected to rounds of refinement with
REFMAC38 and model building with O. In the refinement, data were
Fig. 4 Subunit arrangement of the two types of DHQases: a, The dimer of type I
DHQase from Salmonella typhi; the molecular noncrystallographic dyad is vertical
in the plane of the paper. b, The dodecamer of type II DHQase from
Mycobacterium tuberculosis. The 12 subunits of the dodecamer form four trimers
that are arranged in a tetrahedral way (23 symmetry). This view is down the three-
fold axis. Each trimer is colored differently.
a b



































included to a resolution of 2.18 Å using the merged native 1 and 2
data. Prior to the start of refinement, a set of 10% of the total
reflections were assigned to calculate the Rfree value. In the final
stages of refinement solvent was fitted using ARP39. No electron
density was obtained for amino acids 19–24, which are most likely
to be disordered.
Coordinates. The coordinates for both structures have been
deposited in the Protein Databank (accession code numbers 1qfe
for type I DHQase and 2dhq for type  II enzyme).
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Table 1 Crystallographic data and statistics for type I DHQase from S. typhi and type II DHQase from M. tuberculosis
Type I DHQase Type II DHQase
Native K2Pt(NO2)4 HgCl2 K2PtCl6 K2Pt(NO2)4 UO2(NO3) Native Native Hg(CN)2 Hg(CN)2 K2PtCl4
(1) (2) (1) (2)
Data collection
X-ray source1 E E H H H E D S S D D
Wavelength (Å) 1.54 1.54 0.928 0.928 0.928 1.54 0.89 1.54 1.54 0.99 1.44
Resolution (Å) 2.1 2.3 1.98 2.4 2.4 3.2 2.0 3.98 3.98 2.22 4.2
Completeness (%) 86.1 93.3 98.0 96.7 99.6 99.6 96 99.7 99.7 98.9 92.2
Rmerge (%)2 10.4 8.7 8.2 3.4 5.3 10.2 4.3 7.1 6.2 6.6 12.5
Riso (%)3 20.8 16.0 25.5 29.3 14.6 15.8 10.5 23.9
MIR phasing
Soak (mM/time) 5/3 h 3/1 day 3/1 day 5/1 day 3/3 days 1/1 min 0.1/5 min 1/5 min
No. of sites 8 5 6 7 4 1 1 1
Phasing power4 1.75 1.56 1.15 1.12 1.36 1.6 0.8 0.7
Type I DHQase Type II DHQase Type I DHQase Type II DHQase
Data Stereochemistry
Resolution (Å) 2.1 2.0 Ramachandran quality (%)
Rwork (%) 19.9 14.7 Most favored regions 92.5 97.3
Rfree (%) 24.7 19.6 Allowed regions 7.5 2.7
No. of reflections: R.m.s. deviation:
Total 66,770 37,418 Bond length (Å) 0.010 0.014
Unique 23,517 11,412 Bond angle (º) 1.5 1.7
1D, Beamline 9.5 at the CCLRC Daresbury Laboratory, UK. S, Siemens X-1000 area detector (Glasgow). E, Enraf-Nonius FR571 generator, MAR image
plate (Edinburgh). H, Stations X31 and X11 at EMBL Outstation, Hamburg.
2Rmerge = åh (åj |Ij,h - <Ih>| / åIj,h), where h = reflection (hkl); j = all observations of reflection h.
3Riso = åh ||FPH| - |FP/|| / åh|FP|, where |FPH|, |FP| are observed derivative and native structure factor amplitudes, respectively.
4[åh |FH|2 / åh |E|2]
1/2 where |FH| is the calculated heavy-atom structure factor amplitude and åh |E|2 = åh [|FPH|obs - |FPH|calc]2
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